KOPS - Das Institutionelle Repositorium der Universität Konstanz

Progressive Degeneration of Human Mesencephalic Neuron Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway

Progressive Degeneration of Human Mesencephalic Neuron Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:5ded1685669b71af207a2f54b57388c4

LOTHARIUS, Julie, Jeppe FALSIG, Johan van BEEK, Sarah PAYNE, Ralf DRINGEN, Patrik BRUNDIN, Marcel LEIST, 2005. Progressive Degeneration of Human Mesencephalic Neuron Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway. In: Journal of Neuroscience. 25(27), pp. 6329-6342. ISSN 0270-6474. eISSN 1529-2401

@article{Lotharius2005-07-06Progr-8426, title={Progressive Degeneration of Human Mesencephalic Neuron Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway}, year={2005}, doi={10.1523/JNEUROSCI.1746-05.2005}, number={27}, volume={25}, issn={0270-6474}, journal={Journal of Neuroscience}, pages={6329--6342}, author={Lotharius, Julie and Falsig, Jeppe and Beek, Johan van and Payne, Sarah and Dringen, Ralf and Brundin, Patrik and Leist, Marcel} }

<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/8426"> <dc:language>eng</dc:language> <dc:creator>Leist, Marcel</dc:creator> <dc:creator>Brundin, Patrik</dc:creator> <dc:contributor>Lotharius, Julie</dc:contributor> <dc:contributor>Dringen, Ralf</dc:contributor> <dc:creator>Falsig, Jeppe</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:title>Progressive Degeneration of Human Mesencephalic Neuron Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway</dcterms:title> <dc:contributor>Brundin, Patrik</dc:contributor> <dc:contributor>Beek, Johan van</dc:contributor> <dcterms:abstract xml:lang="eng">Models of Parkinson's disease (PD) based on selective neuronal death have been used to study pathogenic mechanisms underlying nigral cell death and in some instances to develop symptomatic therapies. For validation of putative neuroprotectants, a model is desirable in which the events leading to neurodegeneration replicate those occurring in the disease.Wedeveloped ahumanin vitro model ofPDbased on the assumption that dysregulated cytoplasmic dopamine levels trigger cell loss in this disorder. Differentiated human mesencephalic neuron-derived cells were exposed to methamphetamine (METH) to promote cytoplasmic dopamine accumulation. In the presence of elevated iron concentrations, as observed in PD, increased cytosolic dopamine led to oxidative stress, c-Jun N-terminal kinase (JNK) pathway activation, neurite degeneration, and eventually apoptosis. We examined the role of the mixed lineage kinases (MLKs) in this complex degenerative cascade by using the potent inhibitor 3,9-bis[(ethylthio)methyl]-K-252a (CEP1347). Inhibition of MLKs not only prevented FeCl2+/METH-induced JNK activation and apoptosis but also early events such as neurite degeneration and oxidative stress. This broad neuroprotective action of CEP1347 was associated with increased expression of an oxidative stress-response modulator, activating transcription factor 4. As a functional consequence, transcription of the cystine/glutamate and glycine transporters, cellular cystine uptake and intracellular levels of the redox buffer glutathione were augmented. In conclusion, this new human model of parkinsonian neurodegeneration has the potential to yield new insights into neurorestorative therapeutics and suggests that enhancement of cytoprotective mechanisms, in addition to blockade of apoptosis, may be essential for disease modulation.</dcterms:abstract> <dc:creator>Beek, Johan van</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:43:31Z</dc:date> <dcterms:issued>2005-07-06</dcterms:issued> <dc:creator>Lotharius, Julie</dc:creator> <dc:creator>Dringen, Ralf</dc:creator> <dc:contributor>Falsig, Jeppe</dc:contributor> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8426"/> <dcterms:bibliographicCitation>First publ. in: The Journal of Neuroscience ; 25 (2005), 27. - pp. 6329-6342</dcterms:bibliographicCitation> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103416863-3868037-7"/> <dc:creator>Payne, Sarah</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:43:31Z</dcterms:available> <dc:format>application/pdf</dc:format> <dc:contributor>Payne, Sarah</dc:contributor> <dc:rights>deposit-license</dc:rights> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Lotharius2005with_supplFigures.pdf 177

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto